Report Detail

Service & Software Global Drug Repurposing Serveice Market Research Report 2022

  • RnM4489465
  • |
  • 05 September, 2022
  • |
  • Global
  • |
  • 81 Pages
  • |
  • QYResearch
  • |
  • Service & Software

Description:
Highlights

The global Drug Repurposing Serveice market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Drug Repurposing Serveice is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Drug Repurposing Serveice is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The global market for Drug Repurposing Serveice in Cardiovascular Disorders is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global companies of Drug Repurposing Serveice include Anaxomics Biotech SL, Biovista, Chemotargets, IQVIA, Eurofins DiscoverX, NUVISAN and CD ComputaBio, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

Considering the economic change due to COVID-19, Target-centric, which accounted for % of the global market of Drug Repurposing Serveice in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Repurposing Serveice, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repurposing Serveice.

The Drug Repurposing Serveice market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drug Repurposing Serveice market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Repurposing Serveice companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Anaxomics Biotech SL

Biovista

Chemotargets

IQVIA

Eurofins DiscoverX

NUVISAN

CD ComputaBio

Product Type Insights

Global markets are presented by Drug Repurposing Serveice type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Drug Repurposing Serveice are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Drug Repurposing Serveice segment by Type

Target-centric

Drug-centric

Disease-centric

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Repurposing Serveice market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Repurposing Serveice market.

Drug Repurposing Serveice Segment by Application

Cardiovascular Disorders

Central Nervous Disorders

Oncology

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Drug Repurposing Serveice market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Repurposing Serveice market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Drug Repurposing Serveice and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Repurposing Serveice industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Repurposing Serveice.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Repurposing Serveice companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue and gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.a


Table of content:

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug Repurposing Serveice Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Target-centric
  • 1.2.3 Drug-centric
  • 1.2.4 Disease-centric
  • 1.3 Market by Application
  • 1.3.1 Global Drug Repurposing Serveice Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Cardiovascular Disorders
  • 1.3.3 Central Nervous Disorders
  • 1.3.4 Oncology
  • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Drug Repurposing Serveice Market Perspective (2017-2028)
    • 2.2 Drug Repurposing Serveice Growth Trends by Region
    • 2.2.1 Drug Repurposing Serveice Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Drug Repurposing Serveice Historic Market Size by Region (2017-2022)
  • 2.2.3 Drug Repurposing Serveice Forecasted Market Size by Region (2023-2028)
  • 2.3 Drug Repurposing Serveice Market Dynamics
  • 2.3.1 Drug Repurposing Serveice Industry Trends
  • 2.3.2 Drug Repurposing Serveice Market Drivers
  • 2.3.3 Drug Repurposing Serveice Market Challenges
  • 2.3.4 Drug Repurposing Serveice Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top Drug Repurposing Serveice Players by Revenue
    • 3.1.1 Global Top Drug Repurposing Serveice Players by Revenue (2017-2022)
  • 3.1.2 Global Drug Repurposing Serveice Revenue Market Share by Players (2017-2022)
  • 3.2 Global Drug Repurposing Serveice Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Drug Repurposing Serveice Revenue
  • 3.4 Global Drug Repurposing Serveice Market Concentration Ratio
  • 3.4.1 Global Drug Repurposing Serveice Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Serveice Revenue in 2021
  • 3.5 Drug Repurposing Serveice Key Players Head office and Area Served
  • 3.6 Key Players Drug Repurposing Serveice Product Solution and Service
  • 3.7 Date of Enter into Drug Repurposing Serveice Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Drug Repurposing Serveice Breakdown Data by Type

    • 4.1 Global Drug Repurposing Serveice Historic Market Size by Type (2017-2022)
    • 4.2 Global Drug Repurposing Serveice Forecasted Market Size by Type (2023-2028)

    5 Drug Repurposing Serveice Breakdown Data by Application

    • 5.1 Global Drug Repurposing Serveice Historic Market Size by Application (2017-2022)
    • 5.2 Global Drug Repurposing Serveice Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Drug Repurposing Serveice Market Size (2017-2028)
    • 6.2 North America Drug Repurposing Serveice Market Size by Country (2017-2022)
    • 6.3 North America Drug Repurposing Serveice Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe Drug Repurposing Serveice Market Size (2017-2028)
    • 7.2 Europe Drug Repurposing Serveice Market Size by Country (2017-2022)
    • 7.3 Europe Drug Repurposing Serveice Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Drug Repurposing Serveice Market Size (2017-2028)
    • 8.2 Asia-Pacific Drug Repurposing Serveice Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific Drug Repurposing Serveice Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America Drug Repurposing Serveice Market Size (2017-2028)
    • 9.2 Latin America Drug Repurposing Serveice Market Size by Country (2017-2022)
    • 9.3 Latin America Drug Repurposing Serveice Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Drug Repurposing Serveice Market Size (2017-2028)
    • 10.2 Middle East & Africa Drug Repurposing Serveice Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa Drug Repurposing Serveice Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Anaxomics Biotech SL
    • 11.1.1 Anaxomics Biotech SL Company Detail
  • 11.1.2 Anaxomics Biotech SL Business Overview
  • 11.1.3 Anaxomics Biotech SL Drug Repurposing Serveice Introduction
  • 11.1.4 Anaxomics Biotech SL Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.1.5 Anaxomics Biotech SL Recent Development
  • 11.2 Biovista
  • 11.2.1 Biovista Company Detail
  • 11.2.2 Biovista Business Overview
  • 11.2.3 Biovista Drug Repurposing Serveice Introduction
  • 11.2.4 Biovista Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.2.5 Biovista Recent Development
  • 11.3 Chemotargets
  • 11.3.1 Chemotargets Company Detail
  • 11.3.2 Chemotargets Business Overview
  • 11.3.3 Chemotargets Drug Repurposing Serveice Introduction
  • 11.3.4 Chemotargets Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.3.5 Chemotargets Recent Development
  • 11.4 IQVIA
  • 11.4.1 IQVIA Company Detail
  • 11.4.2 IQVIA Business Overview
  • 11.4.3 IQVIA Drug Repurposing Serveice Introduction
  • 11.4.4 IQVIA Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.4.5 IQVIA Recent Development
  • 11.5 Eurofins DiscoverX
  • 11.5.1 Eurofins DiscoverX Company Detail
  • 11.5.2 Eurofins DiscoverX Business Overview
  • 11.5.3 Eurofins DiscoverX Drug Repurposing Serveice Introduction
  • 11.5.4 Eurofins DiscoverX Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.5.5 Eurofins DiscoverX Recent Development
  • 11.6 NUVISAN
  • 11.6.1 NUVISAN Company Detail
  • 11.6.2 NUVISAN Business Overview
  • 11.6.3 NUVISAN Drug Repurposing Serveice Introduction
  • 11.6.4 NUVISAN Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.6.5 NUVISAN Recent Development
  • 11.7 CD ComputaBio
  • 11.7.1 CD ComputaBio Company Detail
  • 11.7.2 CD ComputaBio Business Overview
  • 11.7.3 CD ComputaBio Drug Repurposing Serveice Introduction
  • 11.7.4 CD ComputaBio Revenue in Drug Repurposing Serveice Business (2017-2022)
  • 11.7.5 CD ComputaBio Recent Development
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Disclaimer
    • Summary:
      Get latest Market Research Reports on Drug Repurposing Serveice. Industry analysis & Market Report on Drug Repurposing Serveice is a syndicated market report, published as Global Drug Repurposing Serveice Market Research Report 2022. It is complete Research Study and Industry Analysis of Drug Repurposing Serveice market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,480.00
      6,960.00
      4,062.90
      8,125.80
      684,385.50
      1,368,771.00
      362,746.50
      725,493.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report